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Chicken coccidiosis, caused by Eimeria sp., occurs in almost all poultry farms and
causes huge economic losses in the poultry industry. Although this disease could be
controlled by vaccination, the reduced feed conservation ratio limits the widespread
application of anticoccidial vaccines in broilers because some intermediate and/or low
immunogenic Eimeria sp. only elicit partial protection. It is of importance to enhance
the immunogenicity of these Eimeria sp. by adjuvants for more effective prevention
of coccidiosis. Cytokines have remarkable effects on the immunogenicity of antigens.
Interleukin 2 (IL-2), for example, significantly stimulates the activation of CD8+ T cells
and other immune cells. In this study, we constructed a transgenic Eimeria mitis line
(EmiChIL-2) expressing chicken IL-2 (ChIL-2) to investigate the adjuvant effect of ChIL-
2 to enhance the immunogenicity of E. mitis against its infection. Stable transfected
EmiChIL-2 population was obtained by pyrimethamine selection and verified by PCR,
genome walking, western blotting and indirect immunofluorescence assay. Cellular
immune response, E. mitis-specific IFN-γ secretion lymphocytes in the peripheral
blood mononuclear cells, stimulated by EmiChIL-2 was analyzed by enzyme-linked
immunospot assay (ELISPOT). The results showed that EmiChIL-2 stimulated a higher
cellular immune response compared with that of the wild-type parasite infection in
chickens. Moreover, after the immunization with EmiChIL-2, elevated cellular immune
response as well as reduced oocyst output were observed These results indicated that
ChIL-2 expressed by Eimeria sp. functions as adjuvant and IL-2 expressing Eimeria
parasites are valuable vaccine strains against coccidiosis.
Keywords: transgenic Eimeria mitis, chicken interleukin 2, reproductive potential, cellular immune response,
ELISPOT
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Introduction
Infections by Eimeria sp. occur in almost all poultry farms and
cause approximately £2 billion losses in the poultry industry
1 year (Shirley et al., 2005; Suo et al., 2006). Vaccination with
either the virulent (Coccivac R© and Immucox R©) or the attenuated
(Paracox R© and Livacox R©) live parasites formulations has been
considered the most eﬃcient means for the protection of breeder
and layer ﬂocks from Eimeria sp. infection (Williams, 1998;
Shirley et al., 2005; Suo et al., 2006). When chickens are
inoculated with a live anticoccidial vaccine, the species within
the vaccine will ﬁnish their life cycle in the host intestine and
their oﬀspring oocysts will be excreted into the environment
(litter) together with feces. Immunity against re-infection by
Eimeria species will be boosted when vaccinated chickens “eat”
these oﬀspring oocysts (Williams, 1998; Shirley et al., 2005).
The cell-mediated immunity (CMI) plays a major role in the
host protection against coccidiosis and requires reinfections
to become solid after vaccination (Danforth, 1998; Chapman,
2000). For Eimeria species with high immunogenicity, immunity
boosted by the ﬁrst round oocysts will be solid enough to prevent
further infection by large quantity of oocysts in the litter, but
for those with low or intermediate immunogenicity, immunity
boosted will not be solid enough and re-infection with large
quantity of oocysts will occur, and the large quantity of newly
invaded parasites will produce damage in the intestine and
negatively inﬂuence absorbance of feed, resulting in bad feed
conversion limiting the wide use of anticoccidial vaccines in
broilers (Jeﬀers, 1975; Shirley et al., 2005; Chapman et al., 2013).
Therefore, the enhanced immunogenicity of some Eimeria sp.
such as Eimeria mitis through transfection of adjuvant molecules
is hypothesized to elicit a higher cellular immune response and
eliminate the intracellular pathogens rapidly, a strategy that can
be utilized for the development of an ideal, novel and alternative
coccidiosis vaccine.
Interleukin 2 (IL-2), produced by helper T cells, is a growth
factor that plays a major role in the expansion and diﬀerentiation
of CD4+ and CD8+ eﬀector T cells both in vivo and in vitro
(Pardoll, 2002; Blachere et al., 2006; Rochman et al., 2009), and
in the activation of N K and LA K cells (Grimm et al., 1982;
Trinchieri, 1989). In a mouse model, the exogenous IL-2 added
to a peptide plus CpG-containing oligodeoxynucleotides (CpG
ODN) vaccination regimen dramatically increased the peptide-
vaccine-elicited CD8+ T cell responses 221-fold compared
with those after CpG ODN and peptide vaccination in B16F1
melanoma infection (Addison et al., 1998). Recently, the
mucosal immunization of mice with recombinant Lactococcus
lactis NZ9000, expressing the UreB-IL-2 protein, elicited more
anti-UreB antibodies that speciﬁcally bounded to the puriﬁed
Helicobacter pylori UreB protein (Zhang et al., 2014). Thus, more
research is being conducted to conﬁrm the adjuvant eﬀect of IL-
2 in enhancing immunogenicity of live vaccine strains (Addison
et al., 1998; Zhang et al., 2014).
Here, we hypothesized that chicken IL-2 (ChIL-2), applied
as an adjuvant, enhanced the Eimeria-speciﬁc cell-mediated
immune response in chickens. To verify our hypothesis,
we choose to conduct the experiments with E. mitis, an
intermediately immunogenic Eimeria species, to locally express
ChIL-2. Our results showed that the transgenic E. mitis
expressing ChIL-2 (EmiChIL-2) elicited a higher cellular immune
response than the wild-type E. mitis infection in chickens.
Thus, it is encouraging that other transgenic other Eimeria sp.,
which also express ChIL-2, could be successfully implemented
as an alternative coccidiosis vaccine for wide use in the poultry
industry.
Materials and Methods
Ethics Statement
Our research with animals was approved by the Beijing
Administration Committee of Laboratory Animals and
performed in accordance with the China Agricultural University
Institutional Animal Care and Use Committee guidelines.
Parasite and Animals
Eimeria mitis (Zz strain), used in this study was maintained
by passaging in coccidian-free, 2–5-weeks-old AA broilers. The
procedures for collection, puriﬁcation, and sporulation were
carried out as previously described (Long et al., 1976).
Three-weeks-old SPF chickens were purchased from Merial
Animal Health Co., Ltd. (Beijing, China) and were fed a
pathogen-free diet and water ad libitum.
Plasmid Construction
Total RNA was isolated from the spleen lymphocytes of one 3-
weeks-old SPF chicken by using the TRIzol reagent (Invitrogen,
USA). cDNA was synthesized through the utilization of random
primers and a High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, USA). According to the ChIL-2 sequence
of Gallus gallus (GeneBank Accession number: AF000631.1), the
open reading frame of ChIL-2 was ampliﬁed by PCR via the
use of ChIL-2-F/ ChIL-2-R (Table 1). The Toxoplasma gondii
dihydrofolate reductase-thymidylate synthase (DHFR-TSm2m3)
gene and the enhanced yellow ﬂuorescent gene (EYFP) were
ampliﬁed by PCR through the use of DHFR-F/DHFR-R and
EYFP-F/EYFP-R from pEtADA and pMIC-EYFP/ACTss-RFP
(Huang et al., 2011; Yin et al., 2011), respectively. A fused
DHFR-EYFP gene was obtained by overlapping PCR. All
PCR ampliﬁcations were performed by using the high ﬁdelity
thermostable Pfu DNA polymerase to reduce the mutation
frequency.
The double expression-cassette plasmid, pHDEAAssChIL-2A
(Figure 1A), was constructed based on pHIS-EYFP/ACT-RFP
(Yin et al., 2011). Brieﬂy, the EYFP gene of pHIS-EYFP/ACT-
RFP was replaced by DHFR-EYFP gene following the RFP gene
was replaced by ssChIL- 2 gene ampliﬁed by three round PCR
by the use of the primers ChIL-2-R and ChIL-2-1, ChIL-2-2 and
ChIL-2-3, respectively. A signal sequence (ss) was obtained from
T. gondii GRA 8, which functionally regulates ChIL-2 secretion
(Shi et al., 2009; Zou et al., 2009; Yin et al., 2011). The plasmid
DNA was linearized by the SnaB I restriction enzyme, which
released the two expression cassettes from the backbone of the
plasmid (Figure 1A).
Frontiers in Microbiology | www.frontiersin.org 2 June 2015 | Volume 6 | Article 533
Li et al. EmiChIL-2 stimulated higher cellular immunity
TABLE 1 | Primers used in this study.
Primer name Primer sequences (5′–3′)a Restriction enzyme name
DHFR-F GGTACCATGCAGAAGCCGGTGTGTCTGGTC Kpn I
DHFR-R CAGCTCCTCGCCCTTGCTCACCATGGTGGCGAC –
AGGATCCAAGACAGC
EYFP-F GCTGTCTTGGATCCTGTCGCCACCATGGTGAGC AAGGGCGAGGAGCTG –
EYFP-R CCTAGGTCAAAGCTTCTTGTACAGCTCGTC Avr II
ChlL-2-F ATGATGTGCAAAGTACTGATCT
ChlL-2-1 GTAGCTCGCGCCATGAACGGTCCTTTGATGATGT GCAAAGTACTGATCT –
ChlL-2-2 GTGTTCGTGGTCTTCGCTGTCTTTGGTGTAGCTC GCGCCATGAACGGTCCTTTG –
ChlL-2-3 ACCGGTATGGCTTTACCATTGCGTGTTTCGGCCA Age I
CGGTGTTCGTGGTCTTCGC
ChlL-2-R CCGCGGTTATTTTTGCAGATATCTCAC Sac II
SP-1 GCTTGCAGCACTTCAGACACTCAA —
SP-2 AAAGACAGAAGTGCCAGCAGCAG —
SP-3 CTGCAACATTCAGTGACTTAGCCG —
aRestriction enzyme sites in the sequence are underlined.
Transfection and Selection of EmiChIL-2
For nucleofection of sporozoites, 10 million E. mitis sporozoites,
which had been freshly puriﬁed through a DE-52 cellulose
column and 10 μg linearized DNA plasmid together with 5 μl
SnaB I were subjected to Nucleofector (Clark et al., 2008; Yin
et al., 2011). After nucleofection (Program U-033, AMAXA,
Switzerland), the sporozoites were divided into two equal parts,
one of which was inoculated into cultures of primary chicken
kidney cells (PCKCs) in 25 cm2 ﬂasks (Corning, Costar, USA).
The transient transfection ratio in vitro was observed by a
ﬂuorescence microscope (Olympus IX71, Tokyo, Japan). The
other part of the transfected sporozoites were inoculated equally
into the ileocecal opening of ﬁve 2-days-old chickens via the
cloaca for stable transfection selection. Eighteen hours after the
inoculation, the chickens began a standard diet, supplemented
with 150 ppm pyrimethamine (Sigma, USA; Clark et al., 2008).
Oocysts from feces excreted 5–10 days post infection (dpi) were
collected, and sporulation was performed for next generation
selection, as described before (Table 2; Long et al., 1976).
Genome Walking
To validate the integration of the DNA fragment into the genome
of transgenic E. mitis, genomic DNAwas isolated from sporulated
transgenic oocysts by phenol/chloroform extraction and ethanol
precipitation (Yan et al., 2009) and the ﬂanking sequences to
the 5′ end of the integrated DNA were detected by using a
Genome Walking Kit (Takara, Dalian, China). Speciﬁc reverse
primers, SP1, SP2, and SP3 (Table 1) were designed according
to histone 4 promoter sequence as per kit instructions. After the
PCR ampliﬁcation, the third-round PCR products were selected
and cloned into the pEASY-T1 vector (TransGen Biotech, Beijing,
China). The resulting putative sequences, conﬁrmed by DNA
sequencing, were then analyzed.
Western Blot Analysis
To validate the expression of ChIL-2 in the transgenic E. mitis,
Western blot analysis was performed as previously described (Liu
et al., 2013). Brieﬂy, soluble proteins extracted from EmiChIL-2
and the wild-type E. mitis in addition to the rChIL-2 as positive
control, were resolved by SDS-PAGE and the immunoblot
analysis following standard protocols. The primary antibody in
this assay was the mouse anti-ChIL-2 polyclonal antibody, while
the HRP-conjugated goat anti-mouse IgG (Proteintech, USA)was
used as the secondary antibody.
Indirect Immunofluorescence Assay (IFA)
In order to analyze the distribution of ChIL-2 in transgenic
E. mitis sporozoites, IFA was preformed as previously described
(Huang et al., 2011). Brieﬂy, sporozoites of EmiChIL-2 and
the wild-type E. mitis were, respectively, applied onto poly-L-
lysine-coated slides. The primary and secondary antibodies in
this assay were the mouse anti-ChIL-2 polyclonal antibody and
the Cy3-conjugated goat anti-mouse IgG (Proteintech, USA),
respectively.
Measurement the Reproduction of EmiChIL-2
Twelve 1-week-old AA broilers were divided randomly into three
groups to evaluate the reproduction of the transgenic parasites.
Each bird in the diﬀerent groups was orally inoculated with
1000 E. mitis oocysts suspended in 200 μl PBS, 1000 EmiChIL-
2 oocysts suspended in 200 μl PBS, and 200 μl PBS (as control),
respectively. Fecal samples were collected every 24 h from 3 to
11 dpi. The count of oocysts shed in the feces was determined by
using McMaster egg counting chamber (Jeﬀers, 1975; Haug et al.,
2006).
Enzyme-Linked Immunospot Assay (ELISPOT)
To assess the cell-mediated immune response elicited by
the EmiChIL-2 infection in chickens, twelve 3-weeks-old SPF
chickens were divided randomly into three groups, and each
of them was orally inoculated with 104 of the wild-type
E. mitis oocysts suspended in 200 μl PBS, 104 EmiChIL-
2 oocysts suspended in 200 μl PBS, and 200 μl PBS
(as control) in the diﬀerent groups, respectively. Gamma
interferon (IFN-γ) secretion lymphocyte in the peripheral
blood mononuclear cells (PBMCs) of chickens were analyzed
Frontiers in Microbiology | www.frontiersin.org 3 June 2015 | Volume 6 | Article 533
Li et al. EmiChIL-2 stimulated higher cellular immunity
FIGURE 1 | Construction of transgenic Eimeria mitis expressing
secreted chicken IL-2 (ChIL-2). (A) Schematic of double-cassette expression
vectors. The selection gene [DHFR-Ts-enhanced yellow fluorescent gene
(EYFP)] and ChIL-2 were driven by the histone 4 and actin promoter,
respectively. Signal sequences (ss) from T. gondii GRA 8 regulated the secretion
of ChIL-2. (B) Both the transiently transfected E. mitis sporozoites (a) and the
stable transfected EmiChIL-2 (b) were expressing EYFP. (C) Genomic DNA from
EmiChIL-2 was amplified with the primers ChIL-2-F and ChIL-2-R (giving a
432 bp product) to verify the recombination of ChIL-2, and the primers EYFP-F
and EYFP-R (giving a 726 bp product) to confirm the recombination of EYFP as
a positive control, genomic DNA from wild type E. mitis was used as a control.
(D) Genomic DNA from EmiChIL-2 was amplified with arbitrary degenerate
primers (AP 1, AP 2, AP 3, and AP 4) and specific primers [SP 1, SP 2, and SP
3 (Table 2)] from histone 4 promoter by thermal asymmetric interlaced PCR,
and the products from the third-round PCR were cloned into pEasy-T1 vector
for sequencing. (E) One integration site (Emh_scaff1365) was confirmed by
BLAST from more than 50 clones in the E. mitis GeneDB. (F) Oocysts antigens
extracted from EmiChIL-2 reacted with the poly antibody against ChIL-2
producing a clear band with a size of approximately 14 kd to verify ChIL-2
expression by WB. Recombinant ChIL-2 (with two His 6 tag) and the wild-type
E. mitis oocysts antigens were used as a positive and negative control,
respectively. (G) EmiChIL-2 sporozoites reacted with the poly antibody against
ChIL-2 to confirm the localization of ChIL-2 by IFA, and the wild-type E. mitis
sporozoites were utilized as a control. Bar = 10 μm.
4 weeks after the immunization by ELISPOT, as previously
described (Yin et al., 2013). Brieﬂy, 106 PBMCs from the
PBS, the wild-type E. mitis and the EmiChIL-2 oocysts-
immunized birds were stimulated with 10 μl PBS, 10 μl
E. mitis oocysts antigen (10 μg/ml), and 10 μl PMA
plus ionomycin (10 ng/ml PMA plus ionomycin 5 μg/ml),
respectively. The spots in which IFN-γ secretion lymphocyte was
present were detected after 24-h stimulation, as described by
Yin et al. (2013).
ELISA
To evaluate the humoral immune response stimulated by
EmiChIL-2, twelve 1-week-old AA broilers were divided
randomly into three groups, and each bird in the diﬀerent
groups was subjected to primary immunization with 1000 E. mitis
oocysts suspended in 200 μl PBS, 1000 EmiChIL-2 oocysts
suspended in 200 μl PBS and 200 μl PBS (as control) via oral
route, respectively. Two weeks later, the immunized birds were
boosted with 10,000 E. mitis oocysts suspended in 200 μl PBS,
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TABLE 2 | Stable transfected EmiChIL-2 selection.
Reporter Generation Inoculate dosagea (Oocysts/bird) % Parasite expressing Oocysts output/bird Next selectionb
EYFP 1 1 × 106 1.3 1 × 103 Drug
2 5 × 103 15.7 9.3 × 106 Drug
3 5 × 103 35.8 1.2 × 107 Drug
4 5 × 103 50.5 1.4 × 107 Drug
5 5 × 103 80.3 1.1 × 107 Drug
6 5 × 103 92.3 1.5 × 107 –
7 5 × 103 91.7 2.7 × 107 –
aThe first passage 2-days-old AA broilers were inoculated with transfected Eimeria mitis sporozoites via the cloacal route. The next generations 3 were 3-weeks-old AA
broilers orally infected with sporulated EmiChIL-2 oocysts orally.
bEighteen hours after inoculation, the chickens with transfected sporozoites were began a standard diet, supplemented with 150 ppm pyrimethamine.
10,000 EmiChIL-2 oocysts suspended in 200 μl PBS and 200 μl
PBS (as control). The IgY (IgG) antibody titer in the serum
was analyzed by ELISA, as reported previously (Huang et al.,
2011). In brief, 5 μg/ml E. mitis oocysts antigen were coated
onto the individual wells of the plates, followed by a reaction
with serum (1:100) collected 2 weeks after the primary and boost
immunization. The secondary antibody used in this experiment
was the HRP-conjugated goat anti-chicken IgY Fc fragment
(Bethyl Laboratories, Inc.).
Wild Type E. mitis Challenge
To test the protective immunity stimulated by EmiChIL-2
vaccination against wild type E. mitis infection, 30 3-days-old AA
broilers were divided into three groups, non-immunized (Ctrl),
the wild-type E. mitis-immunized (500 oocysts/bird, WT) and
EmiChIL-2-immunized (500 oocysts/bird, EmiChIL-2) group,
respectively. Chickens were housed in the same condition. New
litter of chopped straw was spread over cages’ bottom 5 cm, and
chickens were fed a coccidian-free diet and water ad libitum. All
the chickens were removed to new cages and challenged with
the wild type E. mitis (104 oocysts /bird) at 21 dpi. Fecal and
litter samples were detected every 48 h post immunization, and
oocysts shedding was measured by McMaster chamber (Jeﬀers,
1975; Haug et al., 2006).
Statistical Analysis
Data were analyzed using the SPSS 12.0 (SPSS Institute
Inc.). Diﬀerences in experimental treatments were tested
using Duncan’s Multiple Range Test following ANOVA with
signiﬁcance reported at P ≤ 0.05.
Results
Construction of Transgenic E. mitis Expressing
ChIL-2 (EmiChIL-2)
To construct a transgenic E. mitis secreting ChIL-2, we adapted
the double expression-cassette plasmid, pHDEAAssChIL-2A
(Figure 1A), in which, ChIL-2 was driven by an actin promoter.
After nucleofection, EYFPwas observed in transgenic sporozoites
(Figure 1Ba) 24 h in vitro. Then, after six continuous passages
(Table 2) under the action of pyrimethamine, we obtained
a positive population with more than 90% expressing EYFP
(Figure 1Bb).
To conﬁrm that we successfully produced a stable transfected
EmiChIL-2, we veriﬁed by PCR (Figure 1C) that the plasmid
was introduced in the parasite genome and by genome walking
that the integration site was Emh_scaﬀ1365 (Figures 1D,E).
The results from the Western blot assay (Figure 1F) and the
IFA (Figure 1G) further evidenced that ChIL-2 was expressed
and secreted by EmiChIL-2, respectively. Taken these data
together, to further evaluate the potential as a novel coccidiosis
vaccine component, we obtained a transgenic E. mitis population
secreting ChIL-2.
Reproduction of EmiChIL-2 vs. the Wild-Type
E. mitis
Reproduction, which reﬂects the parasite biological features and
host resistance, was evaluated by the oocyst shedding dynamics
(Figure 2A) and the total oocyst output (Figure 2B). The
reproduction of EmiChIL-2 was substantially lower than that
of the wild-type E. mitis as the total oocyst output per bird
of EmiChIL-2 was reduced threefold relative to the wild-type
E. mitis (Figure 2B). Meanwhile, the peak of oocyst shedding
of EmiChIL-2 delayed about 24 h compared with that of the
wild-type E. mitis (Figure 2A).
EmiChIL-2 Stimulated a Higher Cellular
Immune Response Compared with the
Wild-Type E. mitis
Eimeria sp. infection in chickens elicits both a humoral and
cellular immune response, whereas the CMI plays a major role
in the host protection against coccidiosis (Chapman et al., 2013).
IFN-γ is an important component of the host protective CMI
(Lillehoj and Choi, 1998). In this study, the IFN-γ secretion
lymphocytes in PBMCs were analyzed post immunization by
ELISPOT. As assumed in our hypothesis, the amount of E. mitis-
speciﬁc IFN-γ secretion lymphocytes was signiﬁcantly higher
in PBMCs of EmiChIL-2 than those of the wild-type E. mitis-
immunized birds (Figures 3A,B). The oocyst output of EmiChIL-
2 was substantially lower (p < 0.05) than the obtained by
the birds, immunized with the wild-type E. mitis (Figure 3C).
Interestingly, the oocyst output from immunized birds with
10,000 oocysts of both EmiChIL-2 and the wild-type (Figure 3C)
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FIGURE 2 | Oocysts shedding of EmiChIL-2. (A) Oocyst shedding was measured every 24 h from 3 to 11 dpi, and the mean value was estimated from four
individuals. The wild-type E. mitis infection was used as a control. (B) Mean total oocyst output per chicken of EmiChIL-2 was three times lower than that of the
wild-type E. mitis (p < 0.05) 3 to 11 days after the infection.
FIGURE 3 | Gamma interferon (IFN-γ) secretion lymphocytes in
peripheral blood mononuclear cells (PBMCs) after immunization. (A) 106
PBMCs from PBS (Ctrl, upper), wild-type E. mitis (middle) and EmiChIL-2
(bottom) immunized birds (104 oocysts/bird) were stimulated for 24 h with PBS
(negative control, left), E. mitis oocysts antigen (middle) and PMA plus
ionomycin (positive control, right). The number of IFN-γ secretion lymphocytes
(spots) was determined as described in the section of materials and methods.
(B) The mean amount of IFN-γ secretion lymphocytes in PBMCs in EmiChIL-2
immunized birds was significantly higher (p < 0.05) than that of the birds
immunized with the wild-type E. mitis (n = 4). (C) Mean total oocyst output per
chicken from 4 to 8 days after the immunization with EmiChIL-2 was much
lower (p < 0.05) than after that, done with the wild-type E. mitis.
was much lower than that from 1000 oocysts-immunized birds
(Figure 2B) as a result of ‘crowding eﬀect’ (Williams, 2001).
The above ﬁndings indicated that EmiChIL-2 stimulated a
higher cellular immune response compared with the wild-type
E. mitis.
EmiChIL-2 Stimulated a Similar Humoral
Immune Response Compared with the
Wild-type E. mitis
Interleukin 2 is a canonical T cell growth factor and plays a role
in the expansion and diﬀerentiation of CD4+ T cells that help
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B lymphocytes secreting immunoglobulins (Zhang et al., 2014).
Here, by the application of ELISA, we evaluated the humoral
immune response, stimulated by EmiChIL-2 after the primary
and boost immunization. However, there was no signiﬁcant
diﬀerence (P > 0.05) in the IgY titers in the serum after both
the primary and the boost immunization of the birds, immunized
with EmiChIL-2 and the wild-type E. mitis (Figure 4A). The
reduced oocyst output of birds, immunized with EmiChIL-2 in
comparison with that of the ones with immunization by the wild-
type parasites (Figure 4B) may be due to CMI rather than on
humoral immunity.
EmiChIL-2 Enhances Protection of Chickens
against Wild Type E. mitis Challenge
Immunization of chickens with anticoccidial vaccines elicits
immunity against Eimeria sp. infection, and the immunity is
automatically boosted when vaccinated chickens ingest oﬀspring
oocysts excreted into litter (Jeﬀers, 1975; Shirley et al., 2005;
Chapman et al., 2013). We examined whether EmiChIL-2
enhanced protection of chickens against wild type E. mitis
challenge with oocyst output reduction as a parameter of
protection. EmiChIL-2 immunized chickens excreted fewer
oocysts as compared with wild type-immunized chickens post
challenge with wild type E. mitis (Figures 5A,B), indicating
ChIL-2 enhanced the immunogenicity of the transgenic parasite.
Discussion
Here, we demonstrated that transgenic E. mitis expressing
secreted ChIL-2 induced a higher cellular immune response
in chickens than did the wild-type E. mitis. Moreover,
the reproduction of the transgenic parasite was reduced
signiﬁcantly. We speculated that the enhanced cellular immune
response stimulated by EmiChIL-2, which rapidly eliminated
the intracellular pathogens, contributed mainly to the reduced
reproduction of EmiChIL-2. The expression of exogenous
proteins and their toxicity to the parasite might have also
inﬂuenced in part the biology features of the parasite, resulting
in the lowered reproduction of EmiChIL-2 (Yan et al., 2009;
Huang et al., 2011). In addition, the expression of EYFP in
FIGURE 4 | IgY (IgG) antibody titer in the serum and oocyst output
post primary and boost immunization. (A) The OD450 value was similar
between the birds immunized with EmiChIL-2 and those, immunized with
the wild-type E. mitis 2 weeks after both the primary and the boost
immunization (p > 0.05). (B) Mean total oocyst output per chicken of
EmiChIL-2 was significantly lower than that of the wild-type E. mitis after
the primary immunization (p < 0.05) 4–8 days, whereas, there was no
significant difference between the EmiChIL-2 and the wild-type
E. mitis-immunized birds after the boost immunization (p > 0.05) 4 to
8 days.
FIGURE 5 | Oocyst output following challenge infection in birds vaccinated with or without EmiChIL-2 or its wild type. (A) Oocysts in fecal and litter
samples (n = 10) every 2 days post vaccination with transgenic or wild type E. mitis and challenge with wild-type E. mitis (104 oocysts/bird). (B) Mean total oocyst
output per chicken between 4 and 8 days post challenge.
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transgenic E. tenella and E. mitis lines elicited EYFP-speciﬁc
immune response but did not alter the Eimeria-speciﬁc immune
response (Huang et al., 2011; our unpublished data). So, the eﬀect
of enhanced Eimeria-speciﬁc cellular immune response in this
study was interpreted here as being due to ChIL-2 secreted by
EmiChIL-2.
Interleukin 2 continuously expressed by L. lactis or by a co-
injection with CpG in a melanoma infection model signiﬁcantly
enhanced both humoral and cellular immune responses in mice
with only one treatment (Addison et al., 1998; Zhang et al.,
2014). In an in vitro cell model, continuous IL-2 secretion is
required for enhancing activation of CD8+ T cell (Steenblock
et al., 2011). These are in consistence with our EmiChIL-2 model,
where ChIL-2 was driven by an actin promoter, a house-keeping
gene promoter, guaranting that ChIL-2 was expressed and
secreted into the parasite infection immune microenvironment
continuously during the whole life cycle (Zou et al., 2009; Yin
et al., 2011).
The ﬁnding that IL-2 expressing E. mitis obtained higher
immunogenicity and protected chickens from wild type E. mitis
infection suggested that the transgenic Eimeria sp. expressing
cytokines, such as ChIL-2, could be utilized as an highly
eﬀective anticoccidial vaccine strains, encouraging our further
transgenesis of IL-2 in some other Eimeria sp., such as
E. tenella and E. necatrix, which are highly pathogenic but have
intermediate immunogenicity. Enhanced immunogenicity helps
vaccinated chickens develop solid immunity quickly, preventing
vaccination side eﬀect through preventing re-infections. We
conclude that transgenic attenuated anticoccidial vaccine strains
are promising for their safe application in broilers.
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